Billy Boyle - Targeted breath analysis: exogenous volatile organic compounds (EVOC) as targeted metabolic probes in Breath Biopsy (Watch Now)

Billy Boyle - Owlstone Medical

View Billy's presentation here, and download the slides here.

Billy Boyle is an engineering graduate from Cambridge University and co-founder of Owlstone Medical. Owlstone Medical has developed the Breath Biopsy platform, with a vision to become the global leader in Breath Biopsy for early disease detection and precision medicine. Owlstone Medical’s Breath Biopsy Services attract global pharmaceutical clients including GSK and AstraZeneca.

The company’s Breath Biopsy platform has gained $38.5m investment since 2016, enabling the world’s largest breath-based clinical trials in lung and colorectal cancer, two of the most common cancer killers worldwide. Owlstone Medical’s mission is to save 100,000 lives and $1.5B in healthcare costs.

Billy is also a judge for the Cancer Research UK (CRUK) Pioneer award and a trustee of the Linacre Institute.